Published on 25 Oct 2023 on Simply Wall St. via Yahoo Finance
Black Diamond Therapeutics Insider Ups Holding By 82% During Year
From what we can see, insiders were net buyers in Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.
Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.
Check out our latest analysis for Black Diamond Therapeutics